Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine - Mohammad Munshi, MD; Alexandra Junge; Karolina Gadaldi, MD; Nikhil Yawalkar, MD; Kristine Heidemeyer, MD (Elsevier, 2020)